402 related articles for article (PubMed ID: 31087368)
1. circLRP6 regulates high glucose-induced proliferation, oxidative stress, ECM accumulation, and inflammation in mesangial cells.
Chen B; Li Y; Liu Y; Xu Z
J Cell Physiol; 2019 Nov; 234(11):21249-21259. PubMed ID: 31087368
[TBL] [Abstract][Full Text] [Related]
2. Circular RNA circRNA_15698 aggravates the extracellular matrix of diabetic nephropathy mesangial cells via miR-185/TGF-β1.
Hu W; Han Q; Zhao L; Wang L
J Cell Physiol; 2019 Feb; 234(2):1469-1476. PubMed ID: 30054916
[TBL] [Abstract][Full Text] [Related]
3. Liquiritigenin attenuates high glucose-induced mesangial matrix accumulation, oxidative stress, and inflammation by suppression of the NF-κB and NLRP3 inflammasome pathways.
Zhu X; Shi J; Li H
Biomed Pharmacother; 2018 Oct; 106():976-982. PubMed ID: 30119269
[TBL] [Abstract][Full Text] [Related]
4. CircTLK1 Downregulation Attenuates High Glucose-Induced Human Mesangial Cell Injury by Blocking the AKT/NF-κB Pathway Through Sponging miR-126-5p/miR-204-5p.
Qiu B; Qi X; Wang J
Biochem Genet; 2022 Oct; 60(5):1471-1487. PubMed ID: 34731387
[TBL] [Abstract][Full Text] [Related]
5. LncRNA CASC2 regulates high glucose-induced proliferation, extracellular matrix accumulation and oxidative stress of human mesangial cells via miR-133b/FOXP1 axis.
Zhang XL; Zhu HQ; Zhang Y; Zhang CY; Jiao JS; Xing XY
Eur Rev Med Pharmacol Sci; 2020 Jan; 24(2):802-812. PubMed ID: 32016985
[TBL] [Abstract][Full Text] [Related]
6. Circ_0000491 Promotes Apoptosis, Inflammation, Oxidative Stress, and Fibrosis in High Glucose-Induced Mesangial Cells by Regulating miR-455-3p/Hmgb1 Axis.
Wang J; Yang S; Li W; Zhao M; Li K
Nephron; 2022; 146(1):72-83. PubMed ID: 34474408
[TBL] [Abstract][Full Text] [Related]
7. Rosiglitazone attenuates high glucose-induced proliferation, inflammation, oxidative stress and extracellular matrix accumulation in mouse mesangial cells through the Gm26917/miR-185-5p pathway.
Zhao D; Guo J; Liu L; Huang Y
Endocr J; 2021 Jul; 68(7):751-762. PubMed ID: 33790061
[TBL] [Abstract][Full Text] [Related]
8. Andrographolide ameliorates diabetic nephropathy by attenuating hyperglycemia-mediated renal oxidative stress and inflammation via Akt/NF-κB pathway.
Ji X; Li C; Ou Y; Li N; Yuan K; Yang G; Chen X; Yang Z; Liu B; Cheung WW; Wang L; Huang R; Lan T
Mol Cell Endocrinol; 2016 Dec; 437():268-279. PubMed ID: 27378149
[TBL] [Abstract][Full Text] [Related]
9. KCNQ1OT1/miR-18b/HMGA2 axis regulates high glucose-induced proliferation, oxidative stress, and extracellular matrix accumulation in mesangial cells.
Li J; Li M; Bai L
Mol Cell Biochem; 2021 Jan; 476(1):321-331. PubMed ID: 32989627
[TBL] [Abstract][Full Text] [Related]
10. Circular RNA circ_0000712 regulates high glucose-induced apoptosis, inflammation, oxidative stress, and fibrosis in (DN) by targeting the miR-879-5p/SOX6 axis.
Zhao L; Chen H; Zeng Y; Yang K; Zhang R; Li Z; Yang T; Ruan H
Endocr J; 2021 Oct; 68(10):1155-1164. PubMed ID: 33980772
[TBL] [Abstract][Full Text] [Related]
11. LncRNA CTBP1-AS2 alleviates high glucose-induced oxidative stress, ECM accumulation, and inflammation in diabetic nephropathy via miR-155-5p/FOXO1 axis.
Wang G; Wu B; Zhang B; Wang K; Wang H
Biochem Biophys Res Commun; 2020 Nov; 532(2):308-314. PubMed ID: 32868076
[TBL] [Abstract][Full Text] [Related]
12. Nobiletin suppresses high-glucose-induced inflammation and ECM accumulation in human mesangial cells through STAT3/NF-κB pathway.
Liu Z; Han Y; Zhao F; Zhao Z; Tian J; Jia K
J Cell Biochem; 2019 Mar; 120(3):3467-3473. PubMed ID: 30499124
[TBL] [Abstract][Full Text] [Related]
13. Metformin inhibits extracellular matrix accumulation, inflammation and proliferation of mesangial cells in diabetic nephropathy by regulating H19/miR-143-3p/TGF-β1 axis.
Xu J; Xiang P; Liu L; Sun J; Ye S
J Pharm Pharmacol; 2020 Aug; 72(8):1101-1109. PubMed ID: 32391614
[TBL] [Abstract][Full Text] [Related]
14. CircHOMER1 aggravates oxidative stress, inflammation and extracellular matrix deposition in high glucose-induced human mesangial cells.
Shu S; Xu Z; Lu H; Li Z; Zhang Y
Nephrology (Carlton); 2022 Dec; 27(12):983-993. PubMed ID: 36181383
[TBL] [Abstract][Full Text] [Related]
15. miR-485 suppresses inflammation and proliferation of mesangial cells in an in vitro model of diabetic nephropathy by targeting NOX5.
Wu J; Lu K; Zhu M; Xie X; Ding Y; Shao X; Chen Y; Liu J; Xu M; Xu Y; Zhou J; Shen X; Zhu C
Biochem Biophys Res Commun; 2020 Jan; 521(4):984-990. PubMed ID: 31727371
[TBL] [Abstract][Full Text] [Related]
16. Long noncoding RNA TUG1 alleviates extracellular matrix accumulation via mediating microRNA-377 targeting of PPARγ in diabetic nephropathy.
Duan LJ; Ding M; Hou LJ; Cui YT; Li CJ; Yu DM
Biochem Biophys Res Commun; 2017 Mar; 484(3):598-604. PubMed ID: 28137588
[TBL] [Abstract][Full Text] [Related]
17. Circular RNA circADAM9 Promotes Inflammation, Oxidative Stress, and Fibrosis of Human Mesangial Cells via the Keap1-Nrf2 Pathway in Diabetic Nephropathy.
Zheng H; Liu X; Song B
Exp Clin Endocrinol Diabetes; 2023 Sep; 131(9):491-499. PubMed ID: 37463596
[TBL] [Abstract][Full Text] [Related]
18. Circ_0000064 knockdown attenuates high glucose-induced proliferation, inflammation and extracellular matrix deposition of mesangial cells through miR-424-5p-mediated WNT2B inhibition in cell models of diabetic nephropathy.
Li J; Min Y; Zhao Q
Clin Exp Nephrol; 2022 Oct; 26(10):943-954. PubMed ID: 35678923
[TBL] [Abstract][Full Text] [Related]
19. circRNA_010383 Acts as a Sponge for miR-135a, and Its Downregulated Expression Contributes to Renal Fibrosis in Diabetic Nephropathy.
Peng F; Gong W; Li S; Yin B; Zhao C; Liu W; Chen X; Luo C; Huang Q; Chen T; Sun L; Fang S; Zhou W; Li Z; Long H
Diabetes; 2021 Feb; 70(2):603-615. PubMed ID: 33472945
[TBL] [Abstract][Full Text] [Related]
20. Circ-AKT3 inhibits the accumulation of extracellular matrix of mesangial cells in diabetic nephropathy via modulating miR-296-3p/E-cadherin signals.
Tang B; Li W; Ji TT; Li XY; Qu X; Feng L; Bai S
J Cell Mol Med; 2020 Aug; 24(15):8779-8788. PubMed ID: 32597022
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
